News and Events




11/2019: Meet our CEO at the CPhI in Frankfurt and Bio-Europe in Hamburg
Do not miss the opportunity to meet Dr. Lars Kober, CEO of UGA Biopharma GmbH at the CPhI in Frankfurt from November 5-8, 2019 as well as at ...read more


09/2019: UGA Biopharma presented the benefits of First CHOice® Media
September 18, 2019: Sarah Herrman, head of the Technology Development Group, presented her data at the conference „New and Emerging Technologies – Biotech meets Medicine“ in Potsdam-Golm. ...read more


05/2019: High Ranking Delegation from China
UGA Biopharma welcomed 28 delegates from China. Representatives from chinese health institutes ...read more


05/2019: ESACT Meeting in Copenhagen
On behalf of all UGA team members, we would like to thank all our customers and partners for their valuable and long-standing ...read more


12/2017: Four projects successfully completed in Q4
Four biosimilar development projects were successfully finalized in Q4. Ready-to-use Research Cell Banks are available for out-licensing now! ...read more


11/2017: New CEO
UGA Biopharma announces that Dr. Lars Kober, who was holding Operational Management for many years took over the management of UGA. ...read more


10/2017: Abzena and UGA Biopharma collaborate to treat MS
See our latest press release using that ...read more


09/2017: First CHOice - product promotion in transkript Vol 9
See the current product promotion for our High-Performance Cell Culture Medium First CHOice® published in transkript journal Vol. 9 page 41 via this ...read more


08/2017: Collaboration between Batavia Biosciences and UGA Biopharma
Both companies have the ambition to provide services and technologies supporting the development of high quality and affordable biopharmaceuticals. Through the partnership, two enzyme expressing ...read more


07/2017: Meet us at "New & Emerging Technologies" in Potsdam
You can meet us at the congress "New & Emerging ...read more


05/2017: UGA Biopharma presented at Bionnale 2017
Pitch presentation "Cell lines for biosimilar and NBE manufacturing + services"...read more


04/2017: Opening of additional development labs at UGA Biopharma
UGA Biopharma will open additional laboratories featuring state-of-the-art equipment at the Hennigsdorf site for cell line development and analytical contract services. The extension is tailor-made ...read more


03/2017: Launch of High Speed Workflow
UGA has launched an improved cell-line-development workflow ("High Speed Workflow"), which guarantees cell line development on a shortened time ...read more



Contact

UGA Biopharma GmbH
Neuendorfstraße 20a
16761 Hennigsdorf
Germany
E-mail:  info@ugabiopharma.com This email address is being protected from spambots. You need JavaScript enabled to view it.
Phone: +49(0)3302 / 2024900